pharmaphorum1d
AstraZeneca reveals $570m investment in Canada
AstraZeneca has unveiled plans to invest around $570 million in Canada and add around 700 new jobs, describing the county as ...
Absci shares jump as analyst lauds 'practical' AI drug company
"In our view, the ability to generate high quality wet-lab data is critical for advancement," analyst says in initiating ...
Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside
Needham analyst has initiated coverage on Absci Corporation (NASDAQ:ABSI), a drug and target discovery company that harnesses ...
Agilysys Stock Tumbles 19% After Earnings Beat. This Is Why.
The hospitality software company reported adjusted earnings of 38 cents per share, beating Wall Street’s call for 31 cents.
Needham initiates Absci shares with Buy rating on strategy
Absci Corp. (NASDAQ:ABSI) shares, currently trading at $3.22, received a positive outlook from Needham as the firm began coverage with a Buy rating and set a price target of $9.00. The stock has shown ...
Absci initiated with a Buy at Needham
Needham analyst Gil Blum initiated coverage of Absci (ABSI) with a Buy rating and $9 price target Absci “stands out from the pack due to its ...
AbSci (ABSI) Gets a Buy from Truist Financial
Truist Financial analyst Srikripa Devarakonda assigned a Buy rating to the stock today. The company’s shares closed last Friday at $2.90.Invest ...